The biggest stories of the day delivered to your inbox.

After hours: January 10 at 6:49:00 PM EST Loading Chart for ETON ...

Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease DEER PARK ...

H.C. Wainwright raised the firm’s price target on Eton Pharmaceuticals (ETON) to $17 from $15 and keeps a Buy rating on the shares. Eton on Friday announced the acquisition of Galzin ...

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report), boosting the price target to $17.00. Discover the latest stocks ...

Widely clear skies this evening. Overnight, extensive and dense mist and fog will form for many areas, lasting for the majority of the night. Continuing very cold. Saturday Areas of extensive and ...

Writing at Six Colors, veteran tech writer Jason Snell thinks Apple’s plan to address the Apple Intelligence summaries mess doesn’t go far enough, and has three suggestions for the company.

The transcript for this audio is currently being generated. If it’s been more than 24 hours since we published the episode, there might be a glitch in our process. Please contact us at feedback@ ...

Altman told Bloomberg in an interview published Sunday that he was left with a "complete mess on my hands" after being reinstated as CEO. On November 17, 2023, OpenAI's board said in a statement ...